Citadel Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.81M | Buy |
128,364
+108,029
| +531% | +$3.23M | ﹤0.01% | 4804 |
|
|
2025
Q4 | $777K | Sell |
20,335
-39,418
| -66% | -$1.28M | ﹤0.01% | 7978 |
|
|
2025
Q3 | $1.43M | Sell |
59,753
-651,504
| -92% | -$12.2M | ﹤0.01% | 6770 |
|
|
2025
Q2 | $10.5M | Buy |
711,257
+186,922
| +36% | +$3.1M | ﹤0.01% | 2950 |
|
|
2025
Q1 | $9.4M | Sell |
524,335
-54,801
| -9% | -$1.11M | ﹤0.01% | 2939 |
|
|
2024
Q4 | $10.1M | Sell |
579,136
-195,953
| -25% | -$3.47M | ﹤0.01% | 2975 |
|
|
2024
Q3 | $10.8M | Buy |
775,089
+134,780
| +21% | +$1.4M | ﹤0.01% | 2779 |
|
|
2024
Q2 | $5.26M | Buy |
640,309
+485,681
| +314% | +$3.27M | ﹤0.01% | 3675 |
|
|
2024
Q1 | $1.19M | Sell |
154,628
-84,172
| -35% | -$710K | ﹤0.01% | 6566 |
|
|
2023
Q4 | $2.15M | Sell |
238,800
-303,762
| -56% | -$2.21M | ﹤0.01% | 5226 |
|
|
2023
Q3 | $4.85M | Buy |
542,562
+509,037
| +1,518% | +$7.18M | ﹤0.01% | 3692 |
|
|
2023
Q2 | $515K | Sell |
33,525
-876,474
| -96% | -$15.9M | ﹤0.01% | 7876 |
|
|
2023
Q1 | $20.5M | Sell |
909,999
-44,095
| -5% | -$937K | ﹤0.01% | 1890 |
|
|
2022
Q4 | $20.1M | Sell |
954,094
-145,596
| -13% | -$3.09M | ﹤0.01% | 1964 |
|
|
2022
Q3 | $27.1M | Sell |
1,099,690
-206,346
| -16% | -$5.33M | 0.01% | 1582 |
|
|
2022
Q2 | $31.6M | Sell |
1,306,036
-132,742
| -9% | -$3.34M | 0.01% | 1425 |
|
|
2022
Q1 | $37.1M | Buy |
1,438,778
+612,402
| +74% | +$16.3M | 0.01% | 1354 |
|
|
2021
Q4 | $25.7M | Buy |
826,376
+24,006
| +3% | +$676K | 0.01% | 1751 |
|
|
2021
Q3 | $19.5M | Buy |
802,370
+777,966
| +3,188% | +$14.3M | ﹤0.01% | 2032 |
|
|
2021
Q2 | $356K | Buy |
24,404
+5,201
| +27% | +$103K | ﹤0.01% | 10858 |
|
|
2021
Q1 | $480K | Sell |
19,203
-945,325
| -98% | -$26.1M | ﹤0.01% | 9764 |
|
|
2020
Q4 | $26.3M | Buy |
964,528
+336,048
| +53% | +$7.85M | 0.01% | 1528 |
|
|
2020
Q3 | $11.6M | Buy |
628,480
+275,585
| +78% | +$5.36M | ﹤0.01% | 2113 |
|
|
2020
Q2 | $7.2M | Buy |
352,895
+238,339
| +208% | +$3.79M | ﹤0.01% | 2604 |
|
|
2020
Q1 | $1.67M | Buy |
+114,556
| New | +$1.72M | ﹤0.01% | 4430 |
|
|
2019
Q4 | – | Sell |
-144,730
| Closed | -$1.68M | – | 9789 |
|
|
2019
Q3 | $1.68M | Sell |
144,730
-204,167
| -59% | -$3.37M | ﹤0.01% | 4775 |
|
|
2019
Q2 | $7.01M | Buy |
348,897
+250,430
| +254% | +$4.94M | ﹤0.01% | 2624 |
|
|
2019
Q1 | $2.23M | Buy |
98,467
+25,789
| +35% | +$570K | ﹤0.01% | 4287 |
|
|
2018
Q4 | $1.65M | Buy |
+72,678
| New | +$1.81M | ﹤0.01% | 4464 |
|
|
2018
Q3 | – | Sell |
-50,851
| Closed | -$1.45M | – | 9701 |
|
|
2018
Q2 | $1.39M | Sell |
50,851
-22,518
| -31% | -$600K | ﹤0.01% | 4672 |
|
|
2018
Q1 | $1.64M | Sell |
73,369
-284,914
| -80% | -$6.79M | ﹤0.01% | 4038 |
|
|
2017
Q4 | $7.55M | Sell |
358,283
-52,554
| -13% | -$1.2M | ﹤0.01% | 2008 |
|
|
2017
Q3 | $10.2M | Sell |
410,837
-196,935
| -32% | -$4.34M | 0.01% | 1578 |
|
|
2017
Q2 | $11.8M | Sell |
607,772
-201,119
| -25% | -$3.65M | 0.01% | 1338 |
|
|
2017
Q1 | $14.9M | Buy |
808,891
+535,720
| +196% | +$10.5M | 0.01% | 1158 |
|
|
2016
Q4 | $5.17M | Buy |
273,171
+204,270
| +296% | +$4.18M | 0.01% | 1968 |
|
|
2016
Q3 | $1.54M | Sell |
68,901
-513,924
| -88% | -$9.78M | ﹤0.01% | 3274 |
|
|
2016
Q2 | $10.4M | Buy |
582,825
+420,273
| +259% | +$6.8M | 0.01% | 1219 |
|
|
2016
Q1 | $2.22M | Buy |
162,552
+12,637
| +8% | +$192K | ﹤0.01% | 2538 |
|
|
2015
Q4 | $2.89M | Buy |
149,915
+18,476
| +14% | +$369K | ﹤0.01% | 2366 |
|
|
2015
Q3 | $2.66M | Buy |
131,439
+17,758
| +16% | +$526K | ﹤0.01% | 2604 |
|
|
2015
Q2 | $3.77M | Buy |
113,681
+70,201
| +161% | +$1.92M | ﹤0.01% | 2332 |
|
|
2015
Q1 | $1.04M | Buy |
43,480
+21,055
| +94% | +$321K | ﹤0.01% | 3871 |
|
|
2014
Q4 | $274K | Buy |
22,425
+20,348
| +980% | +$211K | ﹤0.01% | 5571 |
|
|
2014
Q3 | $19K | Sell |
2,077
-14,136
| -87% | -$166K | ﹤0.01% | 7488 |
|
|
2014
Q2 | $190K | Sell |
16,213
-10,505
| -39% | -$142K | ﹤0.01% | 5624 |
|
|
2014
Q1 | $568K | Buy |
+26,718
| New | +$411K | ﹤0.01% | 4173 |
|
Other funds holding TVTX
AC
PA
VCM
NAMI
Citadel Advisors's TVTX Position: Q1 2026 in Review
Citadel Advisors increased its Travere Therapeutics (TVTX) stake by 531% in Q1 2026, buying an estimated $3.23M and bringing the position to 128,364 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #4804.
Citadel Advisors first reported a position in TVTX in Q1 2014 and has held it in 47 quarters since. The position peaked at $37.1M in Q1 2022. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.
- Citadel Advisors held 128,364 shares of Travere Therapeutics worth $3.81M as of Q1 2026.
- Citadel Advisors bought 108,029 Travere Therapeutics shares in Q1 2026, an estimated $3.23M.
- Travere Therapeutics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4804 holding.
- Citadel Advisors first reported a position in Travere Therapeutics in Q1 2014 and has held it in 47 quarters since.
- Citadel Advisors's Travere Therapeutics position peaked at $37.1M in Q1 2022.
- 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.